Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magmas expression in neoplastic human prostate.

Paul T Jubinsky1, Mary K Short, George Mutema

  • 1Division of Pediatric Hematology/Oncology, Albert Einstein College of Medicine, Bronx, NY, USA. pjubinsk@aecom.yu.edu

Journal of Molecular Histology
|February 11, 2005
PubMed
Summary

Magmas protein is often elevated in prostate cancer, but its expression varies greatly. Further research is needed to determine if Magmas levels can predict prostate cancer outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Technical Reading Comprehension in Preschool and Second-Grade Students.

Behavior analysis in practice·2026
Same author

Integrating Pathogenic Variants, Polygenic Risk Score, and Family History for Prostate Cancer Risk Estimation in Men of African Ancestry.

European urology·2025
Same author

Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment.

Cells·2025
Same author

Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry.

Cancer research communications·2023
Same author

Generalized Verbal Behavior Increases Following a Speaker Immersion Intervention.

The Analysis of verbal behavior·2020
Same author

Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry.

JCO precision oncology·2020

Area of Science:

  • Mitochondrial biology
  • Cancer research
  • Prostate cancer diagnostics

Background:

  • Magmas is a mitochondrial protein involved in protein transport.
  • Elevated granulocyte-macrophage-colony stimulating factor (GM-CSF) receptor levels are noted in prostate cancer.
  • Understanding Magmas expression in prostate cancer is crucial given its role in cellular processes.

Purpose of the Study:

  • To investigate Magmas protein and messenger RNA expression in normal and neoplastic prostate tissues.
  • To correlate Magmas expression levels with prostate cancer characteristics such as clinical stage and Gleason score.

Main Methods:

  • Western blot analysis was used to quantify Magmas protein levels.
  • Immunohistochemistry was employed to assess Magmas protein distribution in tissue samples.

Related Experiment Videos

  • Quantitative real-time PCR was utilized to measure Magmas messenger RNA levels.

    • Main Results:

    • Magmas protein was barely detectable in normal prostate glands but increased in intraepithelial neoplasia and adenocarcinoma.
    • Approximately 50% of prostate adenocarcinomas showed weak Magmas expression, while the rest exhibited intermediate to high levels.
    • Increased Magmas in malignant tissue resulted from higher protein expression, not altered mitochondrial content.
    • In some cases, normal prostate tissue showed higher Magmas messenger RNA than malignant portions, indicating heterogeneous expression.

    Conclusions:

    • Magmas expression in prostate cancer is heterogeneous and not directly correlated with clinical stage or Gleason score.
    • The observed variability suggests Magmas may not be a straightforward biomarker for prostate cancer progression.
    • Further investigation is warranted to explore the potential prognostic significance of Magmas expression in prostate cancer.